SIRT therapy in Turkey typically costs from $24,000 to $32,000 depending on the isotope used and tumor complexity. In the United States, patients pay approximately $55,000 for similar radioembolization procedures. Choosing Turkey offers savings of about 49%. Most treatment plans in Turkish medical centers include the radioactive microspheres, dosimetry, interventional oncology fees, and brief hospitalization.
Bookimed Expert Insight: High-volume centers in Istanbul provide the best value for complex liver cases. Memorial Şişli Hospital was the first in Turkey to earn JCI accreditation. Anadolu Medical Center offers world-class care through its direct affiliation with Johns Hopkins. For those on a budget, Medipol Mega typically runs about $30,000 for full treatment. Their specialists often manage over 1,000 patients daily, ensuring high clinical proficiency. Always confirm if the quote includes the mandatory hepatic angiogram and shunting evaluation.
Why choose Turkey for SIRT therapy?
Access advanced SIRT therapy solutions in trusted clinics .
| Turkey | Austria | Spain | |
| SIRT therapy | from $24,000 | from $17,000 | from $32,000 |
No hidden fees – just official clinic prices. Pay at the clinic for SIRT therapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in SIRT therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your SIRT therapy journey.
Day 1: Arrival
Day 2-3: Pre-Operation
Day 4: SIRT Therapy
Day 5-7: Post-Operation
Week 1-2: Rehabilitation
Week 3-4: Rehabilitation Continuation
Please note that this is a general guideline and individual experiences may vary. Always consult with your healthcare provider for personalized advice.
Dr. Solak specializes in SIRT therapy for various cancers, trained at Hacettepe University Cancer Institute and MD Anderson Cancer Center.
Dr. Alemdar specializes in SIRT therapy with extensive training at Akdeniz University Hospital.
Dr. Ahmet Kemal Firat is a specialist in neuroradiology, oncology, and vascular interventions. He has extensive experience in aneurysm and AVM embolization, radioembolization, chemoembolization, tumor marking, and biopsies. He is skilled in advanced vascular procedures such as dialysis catheter and port insertions.
Dr. Firat completed his medical and specialist training at Hacettepe University. He continued his education with fellowships in neuroradiology and interventional radiology in the USA. He has served as an associate professor at major institutions. Dr. Firat has contributed to the development of minimally invasive treatments. He is known for his innovative work and maintains a strong record of clinical excellence in interventional radiology.
Selective Internal Radiation Therapy (SIRT) is a targeted treatment for liver tumors that delivers radioactive Yttrium-90 (Y-90) microspheres directly via the hepatic artery. It exploits tumor biology to destroy cancer from within using localized beta radiation while preserving healthy liver tissue and surrounding organs.
Bookimed Expert Insight: Turkey dominates this field globally, ranking first with 388 clinics and 7,760 requests served. Expert centers like Anadolu Medical Center maintain IASIOS certification, proving they meet the highest European standards for interventional oncology. Patients often choose Istanbul because specialized centers here offer advanced SPECT scans to prevent radiation leakage into lungs or gut.
Patient Consensus: Expect symptoms like radiation flu including fever and nausea between day 3 and 7. Most feel relieved discovering SIRT provides life-extending palliative benefits with much less systemic impact than traditional chemotherapy.
SIRT success rates for liver cancer typically range from 70% to 90% for disease control. Primary liver cancer (HCC) shows objective response rates between 50% and 78%. Clinically, SIRT serves as a bridge to transplant in 10% to 39% of previously unresectable cases.
Bookimed Expert Insight: Success with SIRT in Turkey often depends on personalized dosimetry, which can double response rates from 36% to 71%. Facilities like Anadolu Medical Center maintain IASIOS certification for interventional oncology. This ensures they follow the specific European standards required for precise radiation mapping and bead distribution.
Patient Consensus: Many patients find SIRT serves as an effective bridge to liver transplantation. They emphasize that tracking tumor markers monthly is essential because early progression can occur even after initial success.
Ideal candidates for SIRT therapy in Turkey include patients with intermediate-stage primary liver cancer or colorectal metastases that are unresectable. Suitable patients must demonstrate preserved liver function, typically Child-Pugh class A or B, and a good performance status. This interventional radiology procedure leverages Y-90 microspheres to target tumors directly.
Bookimed Expert Insight: While SIRT is often a last resort, high-volume centers like Anadolu Medical Center use it as a bridge to transplant. Their affiliation with Johns Hopkins ensures protocols mirror US standards. Patients with unilateral portal vein thrombosis are still candidates here, whereas many smaller clinics may decline these complex cases.
Patient Consensus: Patients emphasize that a full PET-CT workup in Turkey is vital before starting. Many report that younger, fitter individuals under 70 tend to recover significantly faster after the microsphere injection.
Common side effects of SIRT therapy in Turkey primarily involve post-radioembolization syndrome, characterized by temporary fatigue, mild nausea, and abdominal discomfort. Most patients experience these symptoms as the radioactive microspheres target liver tumors while sparing healthy tissue during this internal radiation process.
Bookimed Expert Insight: While many focus on the procedure day, the recovery gap is where quality matters. Top-tier Istanbul centers like Anadolu Medical Center or Medipol Mega incorporate baseline liver-blood testing into their standard SIRT protocols. This data-driven approach allows radiologists to calibrate isotope dosages precisely, significantly reducing the intensity of post-procedure fatigue compared to clinics without integrated oncology-radiology departments.
Patient Consensus: Many patients emphasize planning for 1–4 weeks of extreme fatigue. Staying hydrated and having anti-nausea medication ready are the most frequent practical recommendations shared by those treated.
SIRT therapy in Turkey typically requires 30 to 120 minutes for the actual procedure, though patients remain at the clinic all day for preparation and monitoring. Immediate recovery involves manageable fatigue and nausea for 1 to 2 weeks, with full stamina returning within 8 to 12 weeks.
Bookimed Expert Insight: Anadolu Medical Center and Memorial Şişli lead in SIRT volume, leveraging JCI accreditation and international affiliations like Johns Hopkins. Data shows these centers prioritize a two-stage process: a detailed simulation week followed by the actual radiation delivery. This staged approach is why patients should plan for a 7 to 10-day stay in Istanbul to ensure precise dose mapping and safety.
Patient Consensus: Patients often report persistent fatigue during the first month and emphasize the need for pre-planned rest. Many noted that tumor response is not instant, as the radiation works gradually over several months after the initial procedure.